FDA decision: Saroglitazar by Zydus Therapeutics (in 2026): What will the FDA's decision be on Saroglitazar by Zydus Therapeutics in 2026? a full approval or an accelerated approval
74%a full approval or an accelerated approval
0 ptsover 24hOne venue carries this question.
24h volume$0
Total volume$1.2K
Markets11 venue, 0 priced
ResolvesJan 1, 2027in 3 months
First seenSep 7, 2026
Watching0
Probability history
Market-implied probabilities on Kalshi · All recorded historyDrag to move · pinch or ⌘/Ctrl+scroll to zoom
Based on market prices from Kalshi. These may differ from Predxy’s combined probability above.
Where this question trades
1 venueComparable, not identical. Each venue words the question and its resolution rules its own way: settlement date, source of truth, and edge cases can all differ. Read each venue's rules before treating two prices as the same thing.
- KalshiFDA decision: Saroglitazar by Zydus Therapeutics (in 2026): What will the FDA's decision be on Saroglitazar by Zydus Therapeutics in 2026? a full approval or an accelerated approval74% a full approval or an accelerated approval$0 24h volumeResolution rules →Set your country to see where you can trade.Set your country →
As of Oct 2, 12:56 PM UTC · Market prices are not certainties.